-
January 28, 2022 Psychedelic Business Spotlight — January 28This week in psychedelic business news: A major player begins manufacturing; another rebrands; and one...
-
January 25, 2022 How Rick Doblin Guides Someone Through a Bad Psychedelic TripDifficult trips could be a problem in areas where psychedelics have been decriminalized, which is...
-
January 25, 2022 Psychedelic Beer: The Leadership Elixir of the Ancient Peruvian AndesArcheological research suggests psychedelic beer may have helped rulers of the pre-Incan empire maintain power...
-
January 24, 2022 How to Prepare for Your First Psychedelic Trip in 5 Easy StepsPsilocybin and LSD are becoming more popular and more accessible, but before your first psychedelic...
-
January 21, 2022 Psychedelic Business Spotlight – January 21Catch up on some of the biggest psychedelic business developments that unfolded in the last...
-
January 19, 2022 Majority of Mental Health Patients Support Access to Psychedelics, Survey FindsAmericans continue to open their minds to ketamine, psilocybin, and MDMA treatment for depression, anxiety,...
-
January 18, 2022 Cybin Set to Measure Psychedelic Effects on the Brain Using Kernel Flow’s Revolutionary TechnologyThe technology may be more broadly used in the future for neuroscientific or physiological studies...
-
January 14, 2022 Psychedelic Business Spotlight — January 14This week in psychedelic business news: Another psychedelics company starts trading on OTCQB; another ketamine...
-
January 13, 2022 Can DMT Treat Depression?Welcome to the Psychedelic Spotlight podcast. In this episode, the Psychedelic Investor sits down with...
-
January 12, 2022 Ketamine Trial for Alcohol Use Disorder Delivers Very Promising ResultsAwakn Life Sciences' Head of Ketamine-Assisted Therapy, Professor Celia Morgan, says world’s first controlled trial...
